Alzheimer's Disease (AD) is thought to involve early synapse loss. Familial AD is most often caused by mutations in presenilins, which are the catalytic subunits of g-secretase. Inactivation of g-secretase in adult mice by conditional deletion of its presenilin or nicastrin subunits causes synaptic impairments followed by neurodegeneration, but the relation of the loss of g-secretase acitivity, the observed synaptic impairments, and the neurodegeneration is unclear, as is the connection between these processes and human AD. The present project will focus on clarifying the synaptic function of g-secretase in mature neurons and its relation to neurodegeneration, using mice as a model system. The project proposes four specific aims to address this overall goal. The first two specific aims will mechanistically characterize the synaptic impairments that are caused by g-secretase inactivation in young adult mice in vivo, and analyze their relation to the neurodegeneration that develops at a later stage after g-secretase inactivation. The third and fourth specific aim will then test the hypothesis that at least some of the synaptic functions of g-secretase that are impaired upon its inactivation may be mediated by g-secretase-dependent cleavage of presynaptic neurexins and postsynaptic neuroligins, which are trans-synaptic cell-adhesion molecules that bind to each other and act as master regulators of synaptic properties. Strikingly in this context, neurexins and neuroligins were shown previously to be substrates for g-secretase, were genetically linked to AD, and are arguably the most plausible mediators of g-secretase function at the synapse. To test the involvement of neurexins and neuroligins in the synaptic functions of g-secretase, the project will characterize the site and regulation of the g-secretase- dependent cleavage of neurexins and neuroligins, and probe the function of this cleavage using conditional knockout mice of these molecules. Moreover, the project will examine whether inactivation of neurexin- and/or neuroligin-cleavage promotes neurodegeneration. Viewed together, the experiments of this project will thus not only characterize the synaptic function of g-secretase and its relation to neurodegeneration, but also determine whether the synaptic function of g-secretase involves the cleavage of neurexins and/or neuroligins and whether such cleavage may play a contributory role in the pathogenesis of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
1P50AG047366-01A1
Application #
8849317
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2015-07-01
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Henderson, V W (2018) Progesterone and human cognition. Climacteric 21:333-340
Besser, Lilah M; Kukull, Walter A; Teylan, Merilee A et al. (2018) The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses. J Neuropathol Exp Neurol 77:717-726
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Bilbrey, Ann Choryan; Humber, Marika B; Plowey, Edward D et al. (2018) The Impact of Latino Values and Cultural Beliefs on Brain Donation: Results of a Pilot Study to Develop Culturally Appropriate Materials and Methods to Increase Rates of Brain Donation in this Under-Studied Patient Group. Clin Gerontol 41:237-248
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Kim, Jeehyun; Zhang, Kai; Cai, Weidong et al. (2018) Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications. Neuropsychologia 119:24-33
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064

Showing the most recent 10 out of 117 publications